Abstract: A battery cover assembly for a portable electronic device includes a battery cover, a base body, and a latching member. The battery cover defines a groove. The base body defines two cutouts. The latching member is received in the groove. The latching member includes a main section and two elastic arms. The main section includes two clasps received in the cutouts. The arms are fixed to the groove of the battery cover to allow the battery cover to releasably latch to the base body.

Abstract: A battery cover latching assembly comprises a body member, a battery cover, and two elastic members. One end of the battery cover is rotatably mounted to the body member, the other end of the battery cover is releasably latched to the body member. The two elastic members are sandwiched between the battery cover and the body member, used to prop up the battery cover.

Abstract: An accessory strap fixing structure is positioned on a portable electronic device to assemble an accessory strap. The accessory strap fixing structure includes an assembling space and a rotary element. The assembling space defined in the portable electronic device. The rotary element is rotatably assembled within the assembling space. The rotary element forms a projection for attaching an end of the accessory strap to allow the accessory strap to pass through the assembling space. The invention also discloses a portable electronic device having the accessory strap fixing structure.

Abstract: A portable electronic device comprises a housing and a chip card ejecting mechanism. The housing has a mounting portion defined therein. The ejecting mechanism includes a holder and a controlling module. The holder is slidably accommodated in the mounting portion of the housing. The controlling module includes a button and an ejecting element. The button releasably secures with the holder in the mounting portion. The ejecting element resistes against the holder to provide an elastic force for driving the holder slid. When the button is pressed, the holder is released and the ejecting element ejects the holder outwardly from the mounted portion of the housing.

Abstract: Compositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaiminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described.

Abstract: Compositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may also include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer. The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract.

Abstract: Compositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described.

Abstract: Nucleic acid molecules that encode plant proteins involved in photoperiodism and circadian rhythms are disclosed. These molecules may be introduced into plants in order to alter the photoperiodic and/or circadian clock-based gene expression of the plants.

Abstract: Nucleic acid molecules that encode plant proteins involved in photoperiodism and circadian rhythms are disclosed. These molecules may be introduced into plants in order to alter the photoperiodic and/or circadian clock-based gene expression of the plants.

Abstract: Nucleic acid molecules that encode plant proteins involved in photoperiodism and circadian rhythms are disclosed. These molecules may be introduced into plants in order to alter the photoperiodic and/or circadian clock-based gene expression of the plants.

Abstract: The nucleic acid that encodes the Arabidopsis ELF3 protein, which is involved in photoperiodism and circadian rhythms, is disclosed. This nucleic acid may be introduced into plants in order to alter the photoperiodic and/or circadian clock-based gene expression of the plants.

Abstract: Nucleic acid molecules that encode plant proteins involved in photoperiodism and circadian rhythms are disclosed. These molecules may be introduced into plants in order to alter the photoperiodic and/or circadian clock-based gene expression of the plants.